相关实验视频
Updated: Jul 7, 2025
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.4K
在视网母细胞瘤中使用rAAV2-RB1-介导基因疗法
Hanhan Shi1,2, Xiaoyu He1,2, Zhi Yang1,2
1Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, People's Republic of China.
Investigative ophthalmology & visual science
|December 22, 2023
概括
在临床前模型中,使用复合腺相关病毒2 (rAAV2) 的基因治疗有效地恢复了RB1蛋白的功能,并抑制了视网膜母细胞瘤 (RB) 的进展. 这种方法为RB患者提供了潜在的化疗独立治疗.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 基因治疗 基因治疗
背景情况:
- 视网母细胞瘤 (RB) 是一种严重的视网膜癌症,由RB1瘤抑制基因失活引起.
- 通过基因疗法向RB1是一个有前途的策略,但众多的RB1突变部位使直接基因修复复杂化.
- 对于RB治疗有必要制定有效的基因治疗策略.
研究的目的:
- 开发和验证一种表达RB1基因的复合腺相关病毒2 (rAAV2) 载体,用于视网膜母细胞瘤治疗.
- 在临床前RB模型中评估rAAV2-RB1基因治疗的体外和体内疗效和生物安全性.
主要方法:
- 构建了一个表达RB1基因的rAAV2向量 (rAAV2-RB1).
- 在患者衍生的RB细胞 (体外) 和小鼠模型 (体内) 中验证了RB1蛋白表达和功能.
- 使用RB患者衍生的异种移植模型评估治疗疗效,并评估免疫能力强小鼠的生物安全性.
主要成果:
- rAAV2-RB1在患者衍生RB细胞中成功表达了RB1蛋白.
- 在异种移植模型中,rAAV2-RB1的静脉内给药限制了瘤的生长.
- rAAV2-RB1证明了生物安全性,在小鼠中没有在其他器官中复制,只有轻微的局部副作用.
结论:
- rAAV2-RB1代表了对视网膜母细胞瘤的一个有前途的基因治疗策略.
- 这种方法可能为RB患者提供一种新的化疗独立治疗选择.
相关概念视频
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K